A randomized double-blind study of timolol in patients with essential hypertension
Guevara, J.; Sukerman, M.; Velasco, M.
Current Therapeutic Research 18(4): 534-538
1975
ISSN/ISBN: 0011-393X PMID: 215 Document Number: 95715
Document emailed within 1 workday
Related Documents
Batlouni, M.; Armaganijan, D.; Campos, C.R. 1986: Clinico-ergometric evaluation of timolol maleate in stable angina: double-blind, randomized and crossed study Arquivos Brasileiros de Cardiologia 46(2): 143-146Whelton, P.K.; Russell, R.P.; Sova-Schulz, K.; Wyndham, R.; Walker, W.G. 1979: Comparison of prazosin and methyldopa in essential hypertension: results of a randomized, double-blind, parallel trial Journal of Cardiovascular Pharmacology 1(6 Suppl): S28-S37
Schmieder, R.E.; Martus, P.; Klingbeil, A. 1996: Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies JAMA 275(19): 1507-1513
Fromantin, M. 1979: Effect and tolerance of Phanurane in the treatment of essential hypertension. (Double blind study) La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 55(41-42): 1965-1967
Angelino, P.F.; Alvino-Demartino, A.; Mappa, R.; Donati, C. 1985: Double-blind crossover study of fenquizone compared to chlorthalidone in essential hypertension International Journal of Clinical Pharmacology Therapy and Toxicology 23(9): 501-505
Merté, H.J.; Merkle, W. 1980: Experiences in a double-blind study with different concentrations of timolol and pilocarpine Klinische Monatsblatter für Augenheilkunde 177(4): 443-450
Lindroos, M.; Lehtonen, A. 1984: Timolol and a hydrochlorothiazide-amiloride combination in the treatment of essential hypertension in young and middle-aged patients: a comparative study with once-daily administration International Journal of Clinical Pharmacology Therapy and Toxicology 22(12): 643-645
De Mendonça, J.V.; de Castro Filho, J. 1984: Comparative double-blind, crossover and randomized study of the antihypertensive activity of nifedipine in primary arterial hypertension Arquivos Brasileiros de Cardiologia 43(3): 219-222
Del Vecchio, L.; Pozzi, M.; Salvetti, A.; Maschio, G.; Fusaroli, M.; Rovati, C.; Antonucci, F.; Cascone, C.; Scanferla, F.; Panichi, V.; Sturani, A.; Locatelli, F. 2004: Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril Journal of Nephrology 17(2): 261-269
Bursztyn, M.; Zelig, O.; Or, R.; Nagler, A. 1997: Isradipine for the prevention of cyclosporine-induced hypertension in allogeneic bone marrow transplant recipients: a randomized, double-blind study Transplantation 63(7): 1034-1036
Milei, J.; Lemus, J.; Bernardiner, E. 1986: Ketanserin in the treatment of essential hypertension. a double-blind study against metoprolol and a further long-term open treatment Acta Cardiologica 41(6): 427-441
Zhao, S.; Wang, F.; Yang, K.; Hao, Y.; Li, G.; Yang, M.; Yang, Z. 2014: Efficacy and safety of fluvastatin extended-release tablets in Chinese patients with hyperlipidemia: a multi-center, randomized, double-blind, double dummy, active-controlled, parallel-group study Zhonghua Nei Ke Za Zhi 53(6): 455-459
Martina, B.; Lorz, W.; Frach, B.; Bart, T.; Battegay, E.J. 1999: The effects of mibefradil and enalapril on 24-hour blood pressure control and left ventricular mass in patients with mild to moderate hypertension: double-blind, randomized trial Journal of Cardiovascular Pharmacology 33(4): 647-651
Agnoli, A.; Manna, V.; Martucci, N.; Fioravanti, M.; Ferromilone, F.; Cananzi, A.; D'Andrea, G.; De Rosa, A.; Vizioli, R.; Sinforiani, E. 1988: Randomized double-blind study of flunarizine versus placebo in patients with chronic cerebrovascular disorders International Journal of Clinical Pharmacology Research 8(3): 189-197
Olié, J.P.; Galinowski, A.; Lehert, P.; Lemonnier, F.; Lôo, H. 1993: Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients L'Encephale 19(4): 333-340
Pham, H.T.; Exelbert, L.; Segal-Owens, A.C.; Veves, A. 2002: A prospective, randomized, controlled double-blind study of a moisturizer for xerosis of the feet in patients with diabetes Ostomy/Wound Management 48(5): 30-36
Massari, P.U.; Grosso, S.; de Boccardo, G.; Vásquez, M.C.; Schiavelli, R.O.; Sabbatiello, R.R.; Casadei, D.H.; Rial, M.C.; Jost, L.J.; Túrin, M.D.; Agost Carreño C, A.; Maggiora, E.C.; Gadea, M.M. 1996: A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group Transplantation Proceedings 28(6): 3365-3367
Bjerke, J.R.; Geiger, J.M. 1989: Acitretin versus etretinate in severe psoriasis. a double-blind randomized Nordic multicenter study in 168 patients Acta Dermato-Venereologica. Supplementum 146: 206-207
Nechwatal, W. 1987: Doxazosin and nitrendipine. a double-blind comparative study in patients with mild to moderate hypertension Fortschritte der Medizin 105(34): 679-682
Chugh, S.N.; Dhawan, R.; Kishore, K.; Sharma, A.; Chugh, K. 2001: Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study Journal of the Association of Physicians of India 49: 803-807